CA3115378A1 — Sublingual films comprising apomorphine and an organic base
Assigned to Sumitomo Pharma America Inc · Expires 2012-06-21 · 14y expired
What this patent protects
The invention features sublingual film formulations comprising acid addition salts of apomorphine and a pH neutralizing agent that is an organic base, and methods of treating Parkinson's disease and restless leg syndrome.
USPTO Abstract
The invention features sublingual film formulations comprising acid addition salts of apomorphine and a pH neutralizing agent that is an organic base, and methods of treating Parkinson's disease and restless leg syndrome.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.